In addition to being found as a prognostic marker for gliomas in this article, structural maintenance of chromosomes 4 (SMC4) has also been found to be a survival marker for colorectal cancer (21), breast cancer (22), and prostate cancer (23). This evidence concerns the gene SMC4 and central nervous system cancer.